Literature DB >> 32952814

Postoperative myocardial injury in a patient with left ureteric stone and asymptomatic COVID-19 disease.

Nadeem Kassam1, Omar Aziz2, Ally Zain Ismail3, Rodgers Swai4, Samina Somji1, Robert Mvungi5, Mustaafa Bapumia5, Aliakber Zehri3, Salim Surani6.   

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified on 8thDecember 2019 in Wuhan, Hubei, China, and has since spread globally to become an emergency of international concern. Patients infected with SARS-CoV-2 may be asymptomatic or present with symptoms ranging from mild clinical manifestations: such as fever, cough, and sore throat to moderate and severe form of the disease such as pneumonia and acute respiratory distress syndrome (ARDS). In some patients, SARS-CoV-2 can affect the heart and cause myocardial injury which is evidenced either by electrocardiographic (ECG) changes or by a rise in serum troponin level. Patients with myocardial involvement are generally at risk of developing severe illness and tend to have a poor outcome. We hereby present a case of a hypertensive male patient with undiagnosed, asymptomatic COVID-19, who underwent an emergency urologic procedure for ureteric calculi. He eventually sustained a postoperative myocardial injury resulting in his demise. This case highlights the importance of detailed preoperative assessment and anticipation of complications during this global pandemic. Copyright: Nadeem Kassam et al.

Entities:  

Keywords:  Coronavirus disease 2019 (COVID-19); myocardial infarction; severe acute respiratory syndrome coronavirus 2; ureteric calculi

Mesh:

Year:  2020        PMID: 32952814      PMCID: PMC7467885          DOI: 10.11604/pamj.2020.36.170.23882

Source DB:  PubMed          Journal:  Pan Afr Med J


  7 in total

Review 1.  Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

Authors:  Peter Libby; Joseph Loscalzo; Paul M Ridker; Michael E Farkouh; Priscilla Y Hsue; Valentin Fuster; Ahmed A Hasan; Salomon Amar
Journal:  J Am Coll Cardiol       Date:  2018-10-23       Impact factor: 24.094

2.  [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].

Authors:  C Chen; C Chen; J T Yan; N Zhou; J P Zhao; D W Wang
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2020-07-24

3.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Authors:  Riccardo M Inciardi; Laura Lupi; Gregorio Zaccone; Leonardo Italia; Michela Raffo; Daniela Tomasoni; Dario S Cani; Manuel Cerini; Davide Farina; Emanuele Gavazzi; Roberto Maroldi; Marianna Adamo; Enrico Ammirati; Gianfranco Sinagra; Carlo M Lombardi; Marco Metra
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

4.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

5.  Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.

Authors:  Jing Yang; Ya Zheng; Xi Gou; Ke Pu; Zhaofeng Chen; Qinghong Guo; Rui Ji; Haojia Wang; Yuping Wang; Yongning Zhou
Journal:  Int J Infect Dis       Date:  2020-03-12       Impact factor: 3.623

6.  SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.

Authors:  G Y Oudit; Z Kassiri; C Jiang; P P Liu; S M Poutanen; J M Penninger; J Butany
Journal:  Eur J Clin Invest       Date:  2009-05-06       Impact factor: 4.686

7.  SARS-CoV-2: a potential novel etiology of fulminant myocarditis.

Authors:  Chen Chen; Yiwu Zhou; Dao Wen Wang
Journal:  Herz       Date:  2020-05       Impact factor: 1.740

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.